THE B29 AND MB-1 POLYPEPTIDES ARE DIFFERENTIALLY EXPRESSED DURING HUMAN B-CELL DIFFERENTIATION

被引:69
作者
MASON, DY
VANNOESEL, CJM
CORDELL, JL
COMANSBITTER, WM
MICKLEM, K
TSE, AGD
VANLIER, RAW
VANDONGEN, JJM
机构
[1] UNIV HOSP ROTTERDAM,SOPHIA CHILDRENS HOSP,DEPT PAEDIAT,ROTTERDAM,NETHERLANDS
[2] NETHERLANDS RED CROSS,BLOOD TRANSFUS SERV,CENT LAB,AMSTERDAM,NETHERLANDS
[3] ERASMUS UNIV,DEPT IMMUNOL,3000 DR ROTTERDAM,NETHERLANDS
[4] UNIV OXFORD SIR WILLIAM DUNN SCH PATHOL,MRC,CELLULAR IMMUNOL UNIT,OXFORD OX1 3RE,ENGLAND
关键词
D O I
10.1002/eji.1830221044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Surface immunoglobulin on mouse B cells is associated with a heterodimer comprising the products of the mb-1 and B29 genes. Here we report that antibodies raised against a peptide sequence from the intracytoplasmic C terminus of the B29 murine gene product detect the 37-kDa component of the human heterodimer, indicating that this component in man is also encoded by the B29 gene. The immunocytochemical reactivity of these anti-B29 antibodies was compared with those of antibodies to the mb-1 protein. Of 25 cases of acute lymphoblastic leukaemia (ALL), 24 were positive for mb-1 whereas B29 was expressed in only 13 cases. Most of these B29-positive ALL expressed immunoglobulin mu heavy chain in their cytoplasm (pre-B ALL). In lymphoid tissue sections, anti-B29-labeled B cell follicles in a similar fashion to anti-mb-1, with the striking exception that plasma cells were unreactive for B29, but positive for mb-1. These results suggest that the synthesis of B29 begins later in precursor B cells than that of mb-1, and ceases before the terminal plasmacyte phase.
引用
收藏
页码:2753 / 2756
页数:4
相关论文
共 19 条